KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Capital Leases (2016 - 2021)

Neogenomics (NEO) has disclosed Capital Leases for 12 consecutive years, with $71000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Capital Leases fell 92.66% year-over-year to $71000.0, compared with a TTM value of $71000.0 through Dec 2021, down 92.66%, and an annual FY2021 reading of $71000.0, down 92.66% over the prior year.
  • Capital Leases was $71000.0 for Q4 2021 at Neogenomics, down from $152000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $11.5 million in Q4 2018 and bottomed at $71000.0 in Q4 2021.
  • Average Capital Leases over 5 years is $4.1 million, with a median of $4.3 million recorded in 2017.
  • The sharpest move saw Capital Leases skyrocketed 96.02% in 2017, then tumbled 92.66% in 2021.
  • Year by year, Capital Leases stood at $10.5 million in 2017, then increased by 9.54% to $11.5 million in 2018, then crashed by 72.3% to $3.2 million in 2019, then tumbled by 69.77% to $967000.0 in 2020, then crashed by 92.66% to $71000.0 in 2021.
  • Business Quant data shows Capital Leases for NEO at $71000.0 in Q4 2021, $152000.0 in Q3 2021, and $448000.0 in Q2 2021.